
|
Engineering Single-Cell Bioanalytics for Discovery and Bioprocess Characterization Dr. J Christopher Love
Tuesday, January 24, 2012 2 PM ET
J. Christopher Love is an associate professor in chemical engineering and member of the Koch Institute for Integrative Cancer Research at MIT. In addition, Chris is an associate member at the Eli and Edythe L. Broad Institute, and at the Ragon Institute of MGH, MIT, and Harvard.
|
.jpg)
|
Viral Contamination of Biologics Manufacture: Occurrence and Mitigation
Dr. Raymond Nims
Monday, December 19, 2011 2 PM ET
Viral contamination events are a rare occurrence in the biopharmaceutical industry. In the past, most of the reported viral contamination events have involved hamster cell production substrates. It has only been recently that we have learned about viral contaminations involving human and monkey cell production substrates. Manufacturing processes involving bacterial fermentation also are at risk of viral contamination. elease testing, and purification process validation.
|

|
From Biomass to Biofuels: Breaking the Cellulose Barrier
Dr. Douglas Clark
Wednesday, October 5, 2011 2pm EDT Another approach to develop more stable cellulases is to generate new enzymes by protein engineering. Clark has employed several protein-engineering strategies, including rational design and directed evolution, to create cellulases with improved thermostability and activity profiles tailored to a desired temperature range. These results will be discussed in connection with cellulase structure-stability relationships and the complementarity of bioprospecting and protein engineering for the discovery and generation of new cellulases.
|
.jpg)
|
Tumor Targeting Theory: Physiological Limits from Scaling Analyses, and Design Principles for Better Magic Bullets Dr. K. Dane Wittrup
Tuesday September 26, 2011 2pm EDT Wittrup s research program is focused on protein engineering of biopharmaceutical proteins by directed evolution. Areas of interest include: pretargeted radioimmunotherapy; biological response modification of EGFR; and immunotherapy of cancer via engineered cytokines and vaccines.
|

|
Microengineered Hydrogels for Stem Cell Bioengineering and Tissue Regeneration Dr. Ali Khademhosseini
Tuesday August 23, 2011 4pm EST In this talk, Dr. Khademhosseini will outline his lab s work in controlling the cell-microenvironment interactions by using patterned hydrogels to direct the differentiation of stem cells. In addition, he will describe the fabrication and the use of microscale hydrogels for tissue engineering by using a bottom-up and a top-down approach.
|

|
Providing Energy to a Growing World: Biogasoline and High-efficiency Engines
Dr. Mark Holtzapple
Thursday June 9, 2011, 3pm EST Dr. Holtzapple will describe the challenges of providing energy to a growing world. To address energy needs, he will show how the MixAlco process converts waste biomass into bio-gasoline. Further, he will explain how to reduce the need for gasoline by using a high-efficiency StarRotor engine.
|

|
Engineering and Health Care Dr. Robert Langer Monday, May 16, 2011, 3pm EDT
Dr. Langer will discuss the involvement of engineering in health care, from the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering.
|

|
Cybernetic Approach to Metabolic Modeling Dr. Ramkrishna Doraiswami Tuesday, April 12, 2011, 4pm EST
Cybernetic modeling has evolved for well over two decades. This seminar seeks to: (i) introduce its basic tenets, (ii) expound its relationship to other approaches to modeling metabolism, and (iii) to reveal its unique dynamic capabilities. The framework is shown to provide eloquent support for goal-oriented explanations of regulatory biological phenomena within the cause-and-effect methodology of science through experimental conformation of exacting predictions.
|

|
New Technologies from Engineered Chimeric Proteins Dr. David Wood Monday, March 21, 2011, 2pm EST
Join us to learn about our work with designer fusion proteins that combine domains and functions from unrelated proteins and enzymes. This technology has widespread applications in both bioseparations and biosensing and we look forward to talking about the state of fusion properties in residence and the environment!
|

|
Cell Therapy Bioprocessing Drs. Pete Zandstra and Robert Deans Tuesday, February 8, 2011, 11am EST
As cellular therapies are advancing through clinical development and getting closer to market, close collaborations between stem cell biologists, clinical cell processing technologists, and bioengineers will be required for effective commercialization of this new class of drugs. Please join us as this new industry evolves, and as the technical discipline of Cell Therapy Bioprocesing is emerging.
|

|
Towards Genome Engineering in Chinese Hamster Ovary Cells Dr. Wei-Shou Hu, University of Minnesota Tuesday, December 14, 2010, 2pm EST
Professor Wei-Shou Hu will discuss his group's work on the sequencing of the CHO genome in conjunction with the Society for Biological Engineering.
|
|
Algae to Bioproducts and Biofuels, Challenges and Promising Technologies Dr. Kim Ogden, Department of Chemical Engineering, University of Arizona Tuesday, September 28, 2010 2-3PM EDT
Professor Ogden will provide an overview of the cultivation testbeds, harvesting technology development, modeling, and potential coproducts of algae in its use in bioproducts and biofuels.
|

|
More heat than light: Opportunities for extremely thermophilic microorganisms and enzymes in biofuels production Dr. Robert M. Kelly, Department of Chemical and Biomolecular Engineering, North Carolina State University Thursday, August 26, 2010 2-3PM EDT
Professor Kelly will discuss opportunities for biofuels that relate to extremely thermophilic microorganisms. The genus Caldicellulosiruptor contains extremely thermophilic bacteria, and includes species that produce primary cellulases, which degrade plant biomass to fermentable sugars. A longer-term goal of producing biofuels directly from CO2, thus by-passing photosynthetic processes, will also be discussed.
|

|
Biological Synthesis of Fuels and Chemicals Dr. James C. Liao, Department of Chemical and Biological Engineering, University of California, Los Angeles Thursday, July 22, 2010 2-3PM EDT
Professor Liao will present a metabolic engineering approach using various microorganisms to produce higher alcohols (C3-C8) from renewable carbon source. This strategy leverages the host s highly active amino acid biosynthetic pathway and diverts its 2-keto acid intermediates for alcohol synthesis.
|

|
Modular Biocatalysis Dr. Chaitan Khosla, Chair, Chemical Engineering; Wells H. Rauser and Harold M. Petiprin Professor in the School of Engineering; Professor of Chemical Engineering, Chemistry, and Biochemistry, Stanford University Tuesday, June 29, 2010 2-3PM EDT
Professor Khosla will detail his laboratory's work to understanding the modularity of a class of multifunctional enzymes called polyketide synthases (PKSs). PKSs catalyze the biosynthesis of a broad range of complex natural products in microorganisms, including many well-known and emerging antibiotics.
|